找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Congenital Bleeding Disorders; Diagnosis and Manage Akbar Dorgalaleh Book 2023Latest edition The Editor(s) (if applicable) and The Author(s

[復制鏈接]
樓主: 撕成碎片
21#
發(fā)表于 2025-3-25 05:24:05 | 只看該作者
Combined Factor V and Factor VIII Deficiency, Diagnosis, and Managemente limited due to the unavailability of FV concentrates. Patients with F5F8D do not need lifelong hemostatic replacement therapy. Therapy is necessary upon spontaneous or traumatic bleeding, in the perioperative period, during pregnancy and delivery. When planning a family, it is necessary to take in
22#
發(fā)表于 2025-3-25 09:52:52 | 只看該作者
23#
發(fā)表于 2025-3-25 14:35:19 | 只看該作者
24#
發(fā)表于 2025-3-25 17:43:07 | 只看該作者
25#
發(fā)表于 2025-3-25 23:13:48 | 只看該作者
Book 2023Latest editionld who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees..
26#
發(fā)表于 2025-3-26 02:50:50 | 只看該作者
Sergei M. Sitnik,Viktor I. Makovetskyost CBDs (particularly IPFD) are mild bleeding disorders that seldom require medical intervention. The main therapeutic choice in most CBDs is on-demand therapy, while in others, such as severe cases of hemophilia A and B and FXIII deficiency, primary prophylaxis is the recommended treatment option.
27#
發(fā)表于 2025-3-26 04:21:56 | 只看該作者
https://doi.org/10.1057/9781137349866e therapy is the only curative option, and it has recently been used successfully in selected hemophilia A patients. Current therapeutic options and supportive care significantly improve hemophilia A patients’ quality of life.
28#
發(fā)表于 2025-3-26 10:52:04 | 只看該作者
https://doi.org/10.1057/9781137349866. However, inhibitor formation against FIX occurs up to 10% of the patients and represents a challenge because of the loss of efficacy of replacement therapy and the risk of severe allergic reactions. The use of recombinant FIX concentrates with extended half-life allows now for effective and safe t
29#
發(fā)表于 2025-3-26 14:06:27 | 只看該作者
Determinants of Transnational Involvement,and the impact on the health-related quality of life. Fibrinogen supplementation is the mainstay of bleeding prevention and treatment. In this chapter, we propose an update on the classification, diagnosis, and management of hereditary fibrinogen disorders in several clinical settings.
30#
發(fā)表于 2025-3-26 19:04:09 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-25 22:04
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
宿松县| 恩施市| 长乐市| 屏山县| 长丰县| 广丰县| 腾冲县| 雅安市| 葫芦岛市| 临洮县| 朝阳县| 康保县| 嘉义县| 巫山县| 安吉县| 巴林左旗| 九龙城区| 荣昌县| 敦化市| 靖州| 郑州市| 策勒县| 东宁县| 陇南市| 大港区| 柳州市| 丹东市| 道孚县| 宜兰县| 崇仁县| 将乐县| 喀什市| 克东县| 孝昌县| 舟曲县| 鄂托克旗| 安平县| 湘潭市| 喀喇| 潞城市| 清徐县|